Previous 10 | Next 10 |
BURLINGAME, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today announced that it has completed the sale of approximately $10 million of its common shares pursuant to the Company’s ATM program establis...
Corvus Pharmaceuticals (CRVS): Q1 GAAP EPS of -$0.34 misses by $0.04.Cash, cash equivalents and marketable securities of $68.0MPress Release For further details see: Corvus Pharmaceuticals EPS misses by $0.04
BURLINGAME, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the first quarter ended March 31, 2021. “In the first quarter we i...
Corvus Pharmaceuticals (CRVS): Q4 GAAP EPS of $0.92 beats by $1.16.Cash, cash equivalents and marketable securities of $44.3MPress Release For further details see: Corvus Pharmaceuticals EPS beats by $1.16
BURLINGAME, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the fourth quarter and year ended December 31, 2020. “In 2020, we ...
The following slide deck was published by Corvus Pharmaceuticals, Inc. in conjunction with this event. For further details see: Corvus Pharmaceuticals (CRVS) Investor Presentation - Slideshow
BURLINGAME, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the Company’s management will participate in two upcoming investor conferences in March: The first conference w...
Institutions & Insiders Are Buying These Penny Stocks Right Now If there’s one thing that gets traders excited about penny stocks , it’s when “big buyers” are present. But how would you know a major institution was buying shares of a company? Furtherm...
Are Analysts Right About These Penny Stocks To Buy? Who’s ready for another busy week with penny stocks ? I know after a short week last week – and a volatile one at that – many are anticipating what to expect this week. Surely we’ll see continued attenti...
Gainers: [[RNWK]] +14.1%. [[VIOT]] +8%. [[IMUX]] +7.5%. [[CRVS]] +6.4%. [[OTIC]] +4.4%.Losers: [[PT]] -4.7%. [[OBSV]] -2.8%. [[PETS]] -2.6%. [[EVGN]] -2%. [[EOLS]] -1.7%. For further details see: PETS, IMUX, EVGN and OTIC among after-hours movers
News, Short Squeeze, Breakout and More Instantly...
Corvus Pharmaceuticals Inc. Company Name:
CRVS Stock Symbol:
NASDAQ Market:
Corvus Pharmaceuticals Inc. Website:
Soquelitinib registrational Phase 3 clinical trial in PTCL advancing toward initial enrollment in Q3 2024 Fast track designation underscores unmet need for patients with relapsed or refractory PTCL, an indication with poor overall outcomes and no approved drugs based on randomized trial...
BURLINGAME, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on August 6, 2024 at 4:30 pm ET (1:30 pm PT) to provide a business update an...
Data demonstrated in vitro and in vivo ITK inhibition with soquelitinib induced switching of proinflammatory Th 17 cells into anti-inflammatory T reg cells Publication confirms and extends understanding of ITK inhibition mechanism of action and its potent...